Literature DB >> 2751643

Regulation of the stability of chicken embryo liver delta-aminolevulinate synthase mRNA by hemin.

P D Drew1, I Z Ades.   

Abstract

The effect of hemin on the stability of delta-aminolevulinate (ALA) synthase mRNA was investigated in primary cultures of chicken embryo hepatocytes. Hepatocytes were first incubated with allylisopropylacetamide (AIA) to increase the starting level of ALA synthase mRNA, and then the cells were incubated with alpha-amanitin (1 microgram/ml) to block further transcription of ALA synthase RNA. The rates of depletion of the enzyme's mRNA were then determined by liquid hybridization analyses in cells incubated with or without hemin (10 microM) in the culture medium. The analyses indicated that hemin increased the rate of ALA synthase mRNA degradation. The half-life of the messenger in hepatocytes incubated with hemin was 80 min compared with 220 min in cells incubated without additional hemin in the culture medium. The results thus indicated a novel mechanism by which hemin modulated the biogenesis of ALA synthase in liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751643     DOI: 10.1016/0006-291x(89)91968-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  On the mechanism of induction of chick embryo hepatic delta-aminolaevulinate synthase by translational blockers.

Authors:  G Ryan; I Z Ades
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Circadian rhythms in acute intermittent porphyria--a pilot study.

Authors:  Sebastian Larion; Frederick R Caballes; Sun-Il Hwang; Jin-Gyun Lee; Whitney E Rossman; Judy Parsons; Nury Steuerwald; Ting Li; Vinaya Maddukuri; Gale Groseclose; Carla V Finkielstein; Herbert L Bonkovsky
Journal:  Eur J Clin Invest       Date:  2013-05-08       Impact factor: 4.686

3.  Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.

Authors:  E E Cable; J A Pepe; N C Karamitsios; R W Lambrecht; H L Bonkovsky
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

4.  Lon peptidase 1 (LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase protein by heme in human liver cells.

Authors:  Qing Tian; Ting Li; Weihong Hou; Jianyu Zheng; Laura W Schrum; Herbert L Bonkovsky
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

5.  Haem repression of the housekeeping 5-aminolaevulinic acid synthase gene in the hepatoma cell line LMH.

Authors:  Sridevi Kolluri; Timothy J Sadlon; Brian K May; Herbert L Bonkovsky
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

Review 6.  Therapeutic RNA-silencing oligonucleotides in metabolic diseases.

Authors:  Algera Goga; Markus Stoffel
Journal:  Nat Rev Drug Discov       Date:  2022-02-24       Impact factor: 84.694

7.  Differential regulation of human ALAS1 mRNA and protein levels by heme and cobalt protoporphyrin.

Authors:  Jianyu Zheng; Ying Shan; Richard W Lambrecht; Susan E Donohue; Herbert L Bonkovsky
Journal:  Mol Cell Biochem       Date:  2008-08-22       Impact factor: 3.396

8.  RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria mice.

Authors:  Makiko Yasuda; Lin Gan; Brenden Chen; Senkottuvelan Kadirvel; Chunli Yu; John D Phillips; Maria I New; Abigail Liebow; Kevin Fitzgerald; William Querbes; Robert J Desnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

9.  Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.

Authors:  Amy Chan; Abigail Liebow; Makiko Yasuda; Lin Gan; Tim Racie; Martin Maier; Satya Kuchimanchi; Don Foster; Stuart Milstein; Klaus Charisse; Alfica Sehgal; Muthiah Manoharan; Rachel Meyers; Kevin Fitzgerald; Amy Simon; Robert J Desnick; William Querbes
Journal:  Mol Ther Nucleic Acids       Date:  2015-11-03       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.